Immunohistochemical Staining of Different Tumor Types: Comparison of Ki-S2 and the Anti–Ki-67 Antigen-Specific MoAb Ki-S5
| Diagnosis . | n . | Ki-S2 . | Ki-S5 . | % Ki-S2 . |
|---|---|---|---|---|
| B-CLL | 26 | 4% ± 3% | 14% ± 6% | 28% |
| Burkitt's lymphoma | 21 | 95% ± 18% | 36% ± 9% | 37% |
| Breast cancer | 100 | 17% ± 6% | 43% ± 18% | 39% |
| Malignant melanoma | 18 | 16% ± 6% | 48% ± 22% | 33% |
| Benign nevi | 29 | >1% | 4% ± 3% | 25% |
| Diagnosis . | n . | Ki-S2 . | Ki-S5 . | % Ki-S2 . |
|---|---|---|---|---|
| B-CLL | 26 | 4% ± 3% | 14% ± 6% | 28% |
| Burkitt's lymphoma | 21 | 95% ± 18% | 36% ± 9% | 37% |
| Breast cancer | 100 | 17% ± 6% | 43% ± 18% | 39% |
| Malignant melanoma | 18 | 16% ± 6% | 48% ± 22% | 33% |
| Benign nevi | 29 | >1% | 4% ± 3% | 25% |
Numbers represent the mean and standard deviation of percentages. All tissue samples were routinely processed paraffin sections.
Abbreviation: n, number of cases.